4//SEC Filing
McDonough John 4
Accession 0000899243-20-002026
CIK 0001492674other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 2:58 PM ET
Size
5.1 KB
Accession
0000899243-20-002026
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2020-01-23$1.15/sh−57,417$66,030→ 512,868 total
Footnotes (2)
- [F1]The transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 11, 2018.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.20. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615937
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 2:58 PM ET
- Size
- 5.1 KB